Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Cancer Letters|September 10, 2003
In vitro aflatoxin B1-induced p53 mutationsKin-Tak Chan, Dennis Paul Hsientang Hsieh, Maria Li Lung
Cancer Chemotherapy and Pharmacology|March 9, 2004
Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell lineKin-Tak Chan, Maria Li Lung
Journal of Mass Spectrometry : JMS|January 20, 2006
An enhanced LC-MS/MS method for microcystin-LR in lake waterChien-Ming Li, Ricky Yuan-Yuan Chu, Dennis Paul Hsientang Hsieh
Clinical Lung Cancer|December 2, 2011
Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in TaiwanShih-Wei Lai, Kuan-Fu Liao, Pei-Chun Chen, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|September 29, 2011
Polypharmacy increases the risk of Parkinson's disease in older people in Taiwan: a population-based studyShih-Wei Lai, Li-Ting Su, Chih-Hsueh Lin, et al.
Toxicology and Applied Pharmacology|November 3, 2007
Enhancements of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism and carcinogenic risk via NNK/arsenic interactionHui-Ling Lee, Louis W Chang, Jui-Pin Wu, et al.
Biochemical and Biophysical Research Communications|June 3, 2010
Multiple coding and non-coding RNAs in the Hoxb3 locus and their spatial expression patterns during mouse embryogenesisKin Tak Chan, Jie Qi, Mai Har Sham
Cancer Biomarkers : Section a of Disease Markers|December 28, 2017
Elevated levels of serum nidogen-2 in esophageal squamous cell carcinomaAnnie Wai Yeeng Chai, Arthur Kwok Leung Cheung, Wei Dai, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 10, 2008
Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patientsHui-Ling Lee, Yu-Mei Hsueh, Chi-Jung Chung, et al.
Pageof 16